우리나라 갑상선암의 치료양상 분석(2008-2012년)
Analysis of Therapeutic Modalities of Thyroid Cancer in Korea between 2008 and 2012
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Backgrounds and Objectives: The incidence of thyroid cancer has been increasing in Korea as well as in other countries. The majority of thyroid cancers are papillary thyroid carcinomas and follicular thyroid carcinomas, both of which are classified as differentiated thyroid carcinoma (DTC). Total or near-total thyroidectomy followed by administration of radioactive iodine (RAI) constitutes the initial treatment for DTC. This study was conducted to investigate the therapeutic modalities of surgery and RAI for the treatment of DTC in Korea using claims data provided by the Health Insurance Review and Assessment Service. Materials and Methods: This study was performed in 170,131 (men 29,002, women 141,129) Korean patients with thyroid cancer treated from January 2008 to December 2012. Patients with past history of thyroid cancer prior to 2008 were not included. Results: Total or near total thyroidectomy was done in 83.4%, lobectomy in 14.4%, and subtotal thyroidectomy in 2.2%. Postoperative RAI treatment was performed in 52.7%. Median 100 mCi of RAI was administered at median 89 days after operation, and it was completed with one dose in 66.0%. Thirty mCi was mostly preferred as an initial dose in 35.6%, and subsequently 150 mCi in 25.7%, 100 mCi in 17.5%, and more than 150 mCi in 10.1%. Median cumulative RAI dose was 130 mCi. RAI treatment rate was decreasing during recent 5 years. Conclusion: This is the first nationwide report to investigate the therapeutic modalities of surgery and RAI for the treatment of DTC in Korea.
Abstract
Backgrounds and Objectives: The incidence of thyroid cancer has been increasing in Korea as well as in other countries. The majority of thyroid cancers are papillary thyroid carcinomas and follicular thyroid carcinomas, both of which are classified as differentiated thyroid carcinoma (DTC). Total or near-total thyroidectomy followed by administration of radioactive iodine (RAI) constitutes the initial treatment for DTC. This study was conducted to investigate the therapeutic modalities of surgery and RAI for the treatment of DTC in Korea using claims data provided by the Health Insurance Review and Assessment Service. Materials and Methods: This study was performed in 170,131 (men 29,002, women 141,129) Korean patients with thyroid cancer treated from January 2008 to December 2012. Patients with past history of thyroid cancer prior to 2008 were not included. Results: Total or near total thyroidectomy was done in 83.4%, lobectomy in 14.4%, and subtotal thyroidectomy in 2.2%. Postoperative RAI treatment was performed in 52.7%. Median 100 mCi of RAI was administered at median 89 days after operation, and it was completed with one dose in 66.0%. Thirty mCi was mostly preferred as an initial dose in 35.6%, and subsequently 150 mCi in 25.7%, 100 mCi in 17.5%, and more than 150 mCi in 10.1%. Median cumulative RAI dose was 130 mCi. RAI treatment rate was decreasing during recent 5 years. Conclusion: This is the first nationwide report to investigate the therapeutic modalities of surgery and RAI for the treatment of DTC in Korea.
참고문헌 (11)
- "Ministry of Health & Welfare"[URL]
- American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, "Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer", Thyroid, 19(11), pp.1167~1214 (2009)
- 이가희, "대한갑상선학회 갑상선결절 및 암 진료 권고안 개정안", 대한영상의학회지, 64(4), pp.389~416 (2011), 대한영상의학회
- Bilimoria KY, "Extent of surgery affects survival for papillary thyroid cancer", Ann Surg, 246(3), pp.375~381 (2007)
- Hay ID, "Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444consecutively treated patients", World J Surg, 26(8), pp.879~885 (2002)
- Cho BY, "Changes in the clinicopathological characteristics and outcomes of thyroid cancer in Korea over the past four decades", Thyroid, 23(7), pp.797~804 (2013)
- Sanders LE, "Differentiated thyroid cancer: reexamination of risk groups and outcome of treatment", Arch Surg, 133(4), pp.419~425 (1998)
- Hay ID, "Papillary thyroid microcarcinoma:a study of 900 cases observed in a 60-year period", Surgery, 144(6), pp.980~987 (2008)
- Schlumberger M, "Strategies of radioiodine ablation in patients with low-risk thyroid cancer", N Engl J Med, 366(18), pp.1663~1673 (2012)
- Mallick U, "Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer", N Engl J Med, 366(18), pp.1674~1685 (2012)
- Wartofsky L, "Should patients with papillary microcarcinoma undergo radioiodine ablation?", Endocrine, 44(2), pp.278~279 (2013)